Nuvama Wealth — One Platform

Explore our offerings

Portfolio Management Services

Approx 10+ PMS available

Featured PMS

ICICI Prudential PMS CONTRA

FlexiCap PMS with Large Cap bias

Mutual Funds

Diversify in funds managed by top professionals

Corporate FD

Dependable investments for consistent income and portfolio balance

Alternative Investment
Funds

Approx 15+ AIF available

Featured AIF

MOSAIC Multi Yield Fund - Series 2

A Multi-manager, Multi-strategy approach investing in diversified Performing Credit focussed AIF.

All offerings

Fixed Income

Capital
Markets

Insurance

Managed
Portfolio

Why Nuvama Wealth?

Portfolios Built Around You

We profess right product fitment for holistic portfolio approach.

We prepare real strategies that match your goals, risk appetite and changing needs. With regular reviews, we keep your portfolio moving in the right direction.

Service That Earns Your Trust

We take it personally!

That’s why we focus on real actions, not just words — being dependable, honest and truly caring in every interaction.

Our Platforms

Nuvama
TX3

New on Nuvama Wealth

New Feature

BSE FnO is now live on Nuvama. Take advantage of Tuesday Expiry and Lower Transaction Charges

New Feature

TradingView charts is now live! - Get tools to make informed trading decisions

Update

Access Enhanced reports to stay updated on your most recent investments and positions.

Mobile Update

Download our improved Nuvama Mobile Trader app. Get market updates, manage your investments and trade seamlessly using one app!

Upcoming Webisodes

View All

Webisodes coming soon.
Stay tuned!

Live News

View All

Just Now

KSH International (-2.99% ) : Co Looking At 20% Growth Over FY26 In Volumes - TV

Equity

Just Now

KSH International (-2.99% ) : Expects 85% Capacity Utilization By Fiscal Year 2028-29.

Equity

11 Sep 09:10 AM

Angel One (-2.29% ) : UBS on Angel One Neutral, Target Price ₹360, as the company awaits the revised CAS framework but expects a strong runway for MTF growth; management is not changing guidance or cost spends, views CAS impact on volumes as transient, and expects retail participation, MTF adoption and customer additions to continue supporting growth.

Equity

11 Sep 09:10 AM

ICICI Lombard (-1.23% ) : UBS on ICICI Lombard Neutral, Target Price ₹1,930, as price aggression in the industry persists; management remains prudent on Motor TP reserving with limited incremental impact, while focusing on pricing discipline and avoiding price-led competition, and remains confident of sustaining superior profitability versus the industry.

Equity

11 Sep 09:10 AM

Cipla (-1.83% ) : Macquarie on Cipla Outperform, Target Price ₹1,675, as key observations from the Pithampur plant’s previous inspection regarding Field Alert Report submission appear addressed, though five repeat observations remain; near-term earnings impact is expected to be limited, but microbial contamination and adverse environmental conditions are critical compliance concerns requiring robust remediation and substantial CAPA evidence to satisfy the FDA.

Equity